<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04210479</url>
  </required_header>
  <id_info>
    <org_study_id>MS.19.12.939</org_study_id>
    <nct_id>NCT04210479</nct_id>
  </id_info>
  <brief_title>Comparison of Bladder Filling vs. Non-Filling in Cesarean Hysterectomy for Placenta Percreta</brief_title>
  <official_title>Bladder Filling in Cesarean Hysterectomy for Placenta Percreta: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hatem AbuHashim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The placenta accreta spectrum (PAS) which includes accreta, increta, and percreta represents
      a significant obstetric challenge. PAS complicates as many as 1 per 500 pregnancies and this
      risk is increased with prior cesarean deliveries. Antenatal diagnosis of PAS allows for
      multidisciplinary planning and delivery before the onset of labor and/or vaginal bleeding.
      This approach has reduced maternal morbidity rates. including less blood loss, fewer
      transfusion requirements and, intraoperative urinary tract injury as well as improve fetal
      outcome.

      Ultrasound evaluation is the recommended first-line modality for diagnosing PAS. Ultrasound
      features suggestive of PAS include loss of the normal retroplacental clear zone, attenuation
      of the uterine-bladder interface, reduced retroplacental myometrial thickness, presence of
      intraplacental lacunar spaces, and bridging vessels between the placenta and bladder. A
      systematic review reported that the antenatal diagnosis of PAS significantly lowered the rate
      of urinary tract injury (from 63% to 39%) during cesarean hysterectomies in these cases.

      Unlike other elective cesarean hysterectomies, cesarean hysterectomy with a placenta previa
      increta/percreta, is more difficult. There is a greater need to both keep a margin from the
      vascular cervical-placental mass and simultaneously protect the urinary bladder. Case series
      reported that bladder filling helps the surgeon to more clearly identify the planes of
      dissection and secure the engorged aberrant vessels, thereby reduces bladder injury.
      Accordingly, a prospective randomized study in pregnant patients with placenta previa
      increta/percreta undergoing elective cesarean hysterectomy will be conducted to address this
      important issue.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of urinary bladder injury</measure>
    <time_frame>Intra-operative (i.e. during surgery).</time_frame>
    <description>Unintentional bladder injury during elective cesarean hysterectomy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Placenta Accreta</condition>
  <arm_group>
    <arm_group_label>Filled-bladder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bladder filling with 300ml diluted methylene blue.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non filled-bladder</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Filled-bladder</intervention_name>
    <description>Urinary bladder filling with 300 ml diluted methylene blue</description>
    <arm_group_label>Filled-bladder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>non filled-bladder</intervention_name>
    <description>Pull up the empty (non-filled) urinary bladder using Allis forceps</description>
    <arm_group_label>non filled-bladder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women in their third trimester (35-37 W).

          -  Placenta previa accreta spectrum identified by the Ultrasound (low lying anterior or
             major degree anterior).

          -  With at least one prior cesarean section.

          -  Elective cesarean hysterectomy.

          -  Evidence of gross placental invasion at the time of surgery (FIGO grade 3a.

        Exclusion Criteria:

          -  Patients undergoing conservative treatment.

          -  Emergency cesarean hysterectomy.

          -  No evidence of gross placental invasion at the time of surgery.

          -  Posterior placenta.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hatem Abu Hashim, MD. FRCOG. PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Medicine, Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mostafa Aboelenin, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samnoud General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hatem Abu Hashim, MD.FRCOG.PhD</last_name>
    <phone>+20502300002</phone>
    <email>hatem_ah@hotmail.com</email>
  </overall_contact>
  <results_reference>
    <citation>Matsubara S. Caesarean hysterectomy for placenta praevia accreta: filling the bladder technique to identify an appropriate bladder separation site. J Obstet Gynaecol. 2013 Feb;33(2):163-4. doi: 10.3109/01443615.2012.740525.</citation>
    <PMID>23445140</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 21, 2019</study_first_submitted>
  <study_first_submitted_qc>December 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2019</study_first_posted>
  <last_update_submitted>December 23, 2019</last_update_submitted>
  <last_update_submitted_qc>December 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Hatem AbuHashim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

